Holen Sie sich die Stockscreener-App
308.10
0.93%
-2.90
Schlusskurs vom Vortag:
$311.00
Offen:
$313.7
24-Stunden-Volumen:
159.32K
Relative Volume:
0.51
Marktkapitalisierung:
$11.71B
Einnahmen:
$2.79B
Nettoeinkommen (Verlust:
$320.59M
KGV:
39.75
EPS:
7.75
Netto-Cashflow:
$714.18M
1W Leistung:
+2.26%
1M Leistung:
+18.24%
6M Leistung:
+50.72%
1J Leistung:
+109.09%
1-Tages-Spanne:
$306.87
$314.82
1-Wochen-Bereich:
$302.16
$317.30
52-Wochen-Spanne:
$146.02
$324.06
Evercore Inc Stock (EVR) Company Profile
Firmenname
Evercore Inc
Sektor
Branche
Telefon
212-857-3100
Adresse
55 EAST 52ND STREET, NEW YORK, NY
Vergleichen Sie EVR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVR
Evercore Inc
|
308.10 | 11.71B | 2.79B | 320.59M | 714.18M | 7.75 |
|
MS
Morgan Stanley
|
131.21 | 211.42B | 54.61B | 11.19B | -31.70B | 5.58 |
|
GS
Goldman Sachs Group Inc
|
605.43 | 190.77B | 50.96B | 12.17B | -90.39B | 20.66 |
|
SCHW
Charles Schwab Corp
|
82.60 | 150.69B | 18.74B | 5.15B | 33.11B | 3.00 |
|
HOOD
Robinhood Markets Inc
|
37.65 | 33.02B | 2.41B | 525.00M | 2.16B | -0.93 |
|
TW
Tradeweb Markets Inc
|
136.04 | 29.08B | 1.63B | 448.61M | 797.37M | 1.72 |
Evercore Inc Stock (EVR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-12 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-09-11 | Hochstufung | Goldman | Neutral → Buy |
| 2024-01-29 | Fortgesetzt | Keefe Bruyette | Mkt Perform |
| 2024-01-09 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-22 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-12 | Hochstufung | UBS | Sell → Buy |
| 2023-01-11 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-27 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2022-09-23 | Herabstufung | UBS | Neutral → Sell |
| 2022-01-06 | Herabstufung | Goldman | Buy → Neutral |
| 2021-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-04 | Herabstufung | UBS | Buy → Neutral |
| 2021-04-09 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2021-03-19 | Bestätigt | Goldman | Buy |
| 2021-01-05 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-12-16 | Eingeleitet | Seaport Global Securities | Buy |
| 2020-12-01 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-10-02 | Hochstufung | UBS | Neutral → Buy |
| 2020-08-05 | Hochstufung | Goldman | Neutral → Buy |
| 2020-07-09 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-03-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-06 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-11-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-08-14 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-06 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-05-23 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-07 | Herabstufung | Goldman | Neutral → Sell |
| 2018-11-06 | Eingeleitet | Goldman | Neutral |
| 2018-01-09 | Hochstufung | UBS | Neutral → Buy |
| 2017-05-23 | Herabstufung | Goldman | Buy → Neutral |
| 2017-03-27 | Eingeleitet | Keefe Bruyette | Mkt Perform |
| 2017-02-16 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-02-13 | Herabstufung | Instinet | Buy → Neutral |
| 2016-12-14 | Eingeleitet | BofA/Merrill | Neutral |
| 2016-11-21 | Fortgesetzt | Credit Suisse | Outperform |
Alle ansehen
Evercore Inc Aktie (EVR) Neueste Nachrichten
Analog Devices, Inc. (ADI): Evercore ISI Ups Price Target to $280, Predicts Demand Rebound - Insider Monkey
Atara Biotherapeutics to Participate at the 7th Annual Evercore ISI HealthCONx Conference - Business Wire
Evercore ISI Group Downgrades CBRE Group (CBRE) - MSN
Geron to Participate in the 7th Annual Evercore ISI HealthCONx Conference - Business Wire
Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference - PR Newswire
Apellis Pharmaceuticals to Present at Evercore ISI and Citi Healthcare Conferences | APLS Stock News - StockTitan
Perspective Therapeutics to Present at Piper and Evercore Healthcare Conferences in December | CATX Stock News - StockTitan
Evercore bullish on Fluence stock despite lowered target, highlights growth potential - Investing.com
Burlington Stores (BURL) PT Raised to $340 at Evercore ISI - StreetInsider.com
Nordstrom (JWN) PT Raised to $22 at Evercore ISI - StreetInsider.com
Evercore ISI Group Upgrades Zoom Video Communications (ZM) - MSN
Umoja Biopharma to Present at the 7th Annual Evercore ISI HealthCONx Conference - GlobeNewswire
Danaher to Present at Evercore ISI HealthCONx Conference - Marketscreener.com
Danaher CEO to Present at Evercore ISI HealthCONx Conference in 2024 | DHR Stock News - StockTitan
Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference - GlobeNewswire
Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference - The Manila Times
89bio to Participate in the 7th Annual Evercore HealthCONx Conference - The Manila Times
Fortrea to Present at the Evercore HealthCONx Conference - Yahoo Finance
Dynavax Technologies to Present at Evercore HealthCONx Conference | DVAX Stock News - StockTitan
Waystar CEO to Present at Evercore and Barclays Healthcare Tech Conferences | WAY Stock News - StockTitan
Kiniksa Pharmaceuticals to Present at Evercore ISI HealthCONx Conference | KNSA Stock News - StockTitan
Acumen Pharmaceuticals to Present Alzheimer's Treatment Progress at Evercore Conference | ABOS Stock News - StockTitan
Evercore upgrades Zoom to ‘outperform’ as its reinvention gains momentum By Investing.com - Investing.com Canada
Avidity Biosciences to Present at Evercore ISI HealthCONx Conference | RNA Stock News - StockTitan
Evercore upgrades Zoom to ‘outperform’ as its reinvention gains momentum - Investing.com India
Wave Life Sciences CEO to Present at Evercore and Citi Healthcare Conferences | WVE Stock News - StockTitan
Aura Biosciences CEO to Present at Evercore ISI HealthCONx Conference | AURA Stock News - StockTitan
Zoom Video Communications (NASDAQ:ZM) Stock Rating Upgraded by Evercore ISI - MarketBeat
Rallybio to Present at the 2024 Evercore ISI HealthCONx Conference - Business Wire
Altimmune to Present at Evercore and Piper Sandler Healthcare Conferences in December | ALT Stock News - StockTitan
Akero Therapeutics to Present at the 7th Annual Evercore ISI HealthCONx Conference - The Manila Times
SpringWorks Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference - The Manila Times
SpringWorks Therapeutics to Present at Evercore ISI HealthCONx Conference | SWTX Stock News - StockTitan
ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference - Kirkland Lake Northern News
Nkarta to Present NK Cell Therapy Advances at Evercore HealthCONx Conference | NKTX Stock News - StockTitan
Atea Pharmaceuticals to Present and Provide a Business Update at the 7th Annual Evercore HealthCONx Conference - Yahoo Finance
Avantor, Inc. CEO to Speak at Evercore ISI HealthCONx Conference - MSN
Teva CEO to Present at Evercore ISI HealthCONx Conference: Key Updates Expected | TEVA Stock News - StockTitan
Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference - Yahoo Finance
Spyre Therapeutics to Present at Evercore ISI HealthCONx Conference | IBD Treatment Updates | SYRE Stock News - StockTitan
Third Harmonic Bio to Present at Evercore HealthCONx Conference in December | THRD Stock News - StockTitan
Soaring legal fees in snarled Citgo auction rankle companies - Marketscreener.com
Evercore ISI Boosts CrowdStrike (NASDAQ:CRWD) Price Target to $400.00 - MarketBeat
CrowdStrike Shares Decline Despite Evercore Raising Price Target on Channel Check Insights - GuruFocus.com
CrowdStrike slips even as Evercore ups target on strong channel checks (CRWD) - Seeking Alpha
Marsh & McLennan stock gains momentum as Evercore highlights acquisition synergies - Investing.com India
Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference - Marketscreener.com
Vir Biotechnology CEO to Present at Evercore ISI HealthCONx Conference | VIR Stock News - StockTitan
Marsh & McLennan Companies' (MMC) "Outperform" Rating Reiterated at Evercore ISI - MarketBeat
Coya Therapeutics to Present at Evercore HealthCONx Conference in December | COYA Stock News - StockTitan
Contineum Therapeutics to Present at Evercore HealthCONx Conference 2024 | CTNM Stock News - StockTitan
Finanzdaten der Evercore Inc-Aktie (EVR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):